References
Tan PH, Ellis I, Allison K, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181–5. https://doi.org/10.1111/his.14091.
Ong CT, Campbell BM, Thomas SM, et al. Metaplastic breast cancer treatment and outcomes in 2500 patients: a retrospective analysis of a national oncology database. Ann Surg Oncol. 2018;25(8):2249–60. https://doi.org/10.1245/s10434-018-6533-3.
Martinez EO, Jorns JM, Kong AL, et al. Primary breast neuroendocrine tumors: an analysis of the national cancer database. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12123-w
Mehdi M, Kong AL, Frebault J, Huang S, Huang CC, Cortina CS. Prognostic outcomes of signet ring cell carcinoma of the breast. J Surg Res. 2021;264:138–48. https://doi.org/10.1016/j.jss.2021.02.020.
Geisler L, Mohr R, Lambrecht J, et al. The role of miRNA in the pathophysiology of neuroendocrine tumors. Int J Mol Sci. 2021;22(16):8569. https://doi.org/10.3390/ijms22168569.
Funding
The Project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Award Number UL1TR001436. The content is solely the responsibility of the author(s) and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no disclosures to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Martinez, E.O., Jorns, J.M., Kong, A.L. et al. ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology. Ann Surg Oncol 29, 6347–6348 (2022). https://doi.org/10.1245/s10434-022-12137-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12137-4